BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37114131)

  • 1. Case report: High-risk acute promyelocytic leukemia and COVID-19-related myocarditis one patient, two cytokine storms.
    Ghiaur A; Doran C; Ionescu B; Mohorea-Neata LA; Stancioaica C; Hirjan R; Tatic A; Cirstea M; Vasilache D; Tabac D; Lupescu I; Coriu D
    Front Oncol; 2023; 13():1095154. PubMed ID: 37114131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Respiratory Distress Syndrome in a Patient With Acute Promyelocytic Leukemia: Overlapping Between Differentiation Syndrome and COVID-19.
    Sui J; Kelmenson D; Hu S; Cao L
    J Hematol; 2021 Oct; 10(5):217-220. PubMed ID: 34804311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report].
    Di Micco L; Mirenghi F; Morelli E; De Simone E
    G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
    De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
    Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.
    Kungwankiattichai S; Owattanapanich W; Rattanathammethee T; Rattarittamrong E; Chanswangphuwana C; Polprasert C; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Prayongratana K; Sriswasdi C; Nakhakes C
    Hematology; 2023 Dec; 28(1):2191462. PubMed ID: 36951362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.
    Avvisati G; Lo Coco F; Diverio D; Falda M; Ferrara F; Lazzarino M; Russo D; Petti MC; Mandelli F
    Blood; 1996 Aug; 88(4):1390-8. PubMed ID: 8695858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis and treatment.
    Rego EM; De Santis GC
    Mediterr J Hematol Infect Dis; 2011; 3(1):e2011048. PubMed ID: 22110898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia.
    Hegazy AN; Krönke J; Angermair S; Schwartz S; Weidinger C; Keller U; Treskatsch S; Siegmund B; Schneider T
    BMC Infect Dis; 2022 Jun; 22(1):537. PubMed ID: 35692034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.
    Shenoy SM; Di Vitantonio T; Plitt A; Perez-Johnston R; Gutierrez J; Knorr DA; Stein EM; Liu JE; Feldman S
    Cardiooncology; 2021 Nov; 7(1):39. PubMed ID: 34814948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the management of coagulopathy in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradycardia associated with Multisystem Inflammatory Syndrome in Children with COVID-19: a case series.
    Ciccarelli GP; Bruzzese E; Asile G; Vassallo E; Pierri L; De Lucia V; Guarino A; Lo Vecchio A
    Eur Heart J Case Rep; 2021 Dec; 5(12):ytab405. PubMed ID: 34993395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).
    Inciardi RM; Lupi L; Zaccone G; Italia L; Raffo M; Tomasoni D; Cani DS; Cerini M; Farina D; Gavazzi E; Maroldi R; Adamo M; Ammirati E; Sinagra G; Lombardi CM; Metra M
    JAMA Cardiol; 2020 Jul; 5(7):819-824. PubMed ID: 32219357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Analysis of Children with High-Risk Acute Promyelocytic Leukemia].
    Gao QL; LE SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):33-37. PubMed ID: 36765473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-transretinoic acid (ATRA) treatment-related pancarditis and severe pulmonary edema in a child with acute promyelocytic leukemia.
    Işık P; Çetin I; Tavil B; Azik F; Kara A; Yarali N; Tunc B
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e346-8. PubMed ID: 20881874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions.
    Iyer SG; Elias L; Stanchina M; Watts J
    Front Oncol; 2022; 12():1062524. PubMed ID: 36741714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation Syndrome, a Side Effect From the Therapy of Acute Promyelocytic Leukemia.
    Reyhanoglu G; Hughes B; King KE; Cambridge R
    Cureus; 2020 Dec; 12(12):e12042. PubMed ID: 33447473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia: current strategies for the treatment of newly diagnosed disease.
    Sirulnik LA; Stone RM
    Clin Adv Hematol Oncol; 2005 May; 3(5):391-7, 429. PubMed ID: 16167012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.